What are the guidelines for managing asthma in children in Queensland?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Queensland Guidelines for Asthma Management in Children

The Queensland guidelines for managing asthma in children recommend a stepwise approach to treatment with inhaled corticosteroids (ICS) as the cornerstone of therapy for persistent asthma, alongside appropriate inhaler technique education and written asthma action plans. 1

Diagnosis and Assessment

  • Diagnosis relies on identifying key symptoms:

    • Wheezing
    • Coughing (particularly at night/early morning)
    • Chest tightness
    • Shortness of breath
    • Sleep disturbance due to symptoms 1
  • Assessment should focus on:

    • Impairment (frequency/intensity of symptoms, functional limitations)
    • Risk (likelihood of exacerbations, decline in lung function) 1
    • For young children (0-2 years), diagnosis is more challenging as symptoms may be variable and associated with viral infections 2
  • Severity indicators requiring urgent attention:

    • Inability to speak in sentences
    • Respiratory rate >25/min
    • Heart rate >110/min
    • Oxygen saturation below normal
    • Peak expiratory flow <50% predicted 1

Stepwise Management Approach

  1. Initial Assessment and Inhaler Technique

    • Ensure appropriate inhaler device for child's age
    • Verify correct inhaler technique
    • Educate parents on management principles 2
  2. Treatment Based on Severity

    • Mild Asthma: Low-dose ICS-formoterol as needed or daily low-dose ICS plus as-needed SABA
    • Moderate Asthma: Low-dose ICS-formoterol as maintenance and reliever or medium-dose ICS plus as-needed SABA
    • Severe Asthma: High-dose ICS plus LABA 1
  3. Special Considerations for Young Children (0-2 years)

    • Consider that wheeze/cough may be associated with viral infections without family history of asthma
    • Recognize that bronchodilator response is variable in the first year of life
    • Rule out mimics: gastro-oesophageal reflux, cystic fibrosis, chronic lung disease of prematurity 2

Medication Administration Guidelines

  • Inhaler Devices:

    • Most children cannot use unmodified metered dose inhalers (MDIs) correctly
    • Use large volume spacers with MDIs, especially for inhaled steroids 2
    • For spacer use: actuate MDI, breathe in one puff, repeat actuation, then breathe in second puff 2
  • Inhaled Corticosteroids:

    • Mainstay of preventive treatment
    • Use lowest effective dose for symptom control
    • Monitor growth - short-term reductions in growth rate may occur with doses >400 μg/day 2
    • Every child using inhaled steroids from an MDI should use a large volume spacer 2
  • Relief Medications:

    • Can be repeated 2-4 hourly for acute symptoms
    • Failure to respond requires immediate medical assessment 2
    • For severe exacerbations: oxygen (40-60%), nebulized salbutamol 5-10 mg, systemic corticosteroids, and consider adding ipratropium bromide 0.5 mg 1

Self-Management Education

  • Provide a written asthma action plan that includes:

    • Daily management instructions
    • How to recognize worsening symptoms
    • How to respond to worsening symptoms
    • When to seek emergency care 1
  • Educate patients/parents on:

    • Proper inhaler technique
    • Difference between relievers and preventers
    • Recognition of worsening asthma, especially nocturnal symptoms 2
  • Empower patients/parents to manage treatment rather than requiring doctor consultation before making changes 2

Monitoring and Follow-up

  • Assess treatment outcomes using:

    • Days off school due to asthma
    • Daytime and nighttime cough frequency
    • Frequency of relief medication use
    • Activity limitations and wheeze
    • Appropriateness of inhaler for age and dosages 2
    • Consider peak flow monitoring in children 5 years and older 1
  • Monitor height and weight velocities, particularly in children on inhaled steroids 2

Common Pitfalls to Avoid

  • Underuse of inhaled corticosteroids in persistent asthma 1
  • Overuse of nebulizers (expensive, time-consuming, inefficient) when large volume spacers may be more appropriate 2
  • Failure to address comorbidities that can worsen asthma control 1
  • Inadequate attention to inhaler technique and adherence before escalating therapy 2
  • Not providing written asthma action plans 1

By following these guidelines, healthcare providers in Queensland can effectively manage childhood asthma, minimize symptoms, prevent exacerbations, and improve quality of life for affected children.

References

Guideline

Asthma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.